34.85 1.01%

1M0.00% 1Y -0.00%  

Analysts Review about Glaxosmithkline plc - ADR

Market Consensus (3 Analysts)

Hold

Price Target High $41.39

Spread: 19.98%

Price Target Average $39.80

Spread: 15.36%

Price Target Low $32.91

Spread: -4.61%

Can Google Stock Rebound To $150 In 2023?

AI Stock Breaks Out Ahead Of Earnings; Is AI Stock A Buy Now?

Technical Analyses Trend

Periods

Trend

Resistance

Support

Short Term

Bearish

42.56 (22.13%)

40.77 (16.99%)

Mid Term

Neutral

43.65 (25.24%)

40.77 (16.99%)

Long Term

Neutral

43.65 (25.24%)

34.01 (-2.41%)

  • 1W
  • 1M
  • 1Y

Glaxosmithkline plc - ADR Articles

The Motley Fool

Prediction: These 6 AI Stocks Will Be Worth a Combined $20 Trillion by 2030

The top six AI stocks are currently worth a combined $9.5 trillion. They could reach $20 trillion or more by 2030 via different paths, with AI serving as a key tailwind.

Sentiment: Positive 2023-05-30

Proactive Investors

Sirius Real Estate completes early refinancing of debt

Sirius Real Estate said it completed the early refinancing of its €58.3mln debt facility with Deutsche Pfandbriefbank seven months before the due date. A statement from the owner and operator of business and industrial parks said the refinancing comprises a seven-year €58.3mln facility with a fixed interest rate of 4.25%.

Sentiment: Positive 2023-05-30

Zacks Investment Research

Loan Growth Supports M&T Bank (MTB) Despite Rising Costs

M&T Bank's (MTB) top line gets support from increasing loan and deposit balances. Continued rising expenses keep the bottom line under pressure, while worsening credit quality is worrisome.

Sentiment: Negative 2023-05-30

S&P Stocks Review about Glaxosmithkline plc - ADR

SPS Rank 455th

SPS Rate 4.2

SPS Consensus (08 Analysts) Hold

Target Price 45.20 USD 29.70%

Potentials Very Good

Growth (Revenue) Extremely Poor

Finances Excellent

Profitability Very Good

Earnings Quality Fair

P/E Ratio Poor

Valuation Overvalued

Fair Value 27.26USD -21.77%

Source

Sentiment

2023-05-30 Here's Why Schlumberger (SLB) is a Strong Value Stock

Za

Positive

2023-05-30 Schlumberger Limited: A Bet On Carbon Capture Capabilities

Se

Positive

2023-05-30 P&G stock leads the Dow's losers as debt-ceiling optimism turns investors away from safety of consumer staples

Ma

Negative

2023-05-29 3 Top Growth Stocks to Make You the Millionaire Next Door

In

Positive

2023-05-29 3 Tech Stocks That Will Reign Supreme in the New World

In

Positive

2023-05-29 The 7 Best Dividend Stocks to Buy for Your Grandchildren

In

Positive

2023-05-29 Caterpillar, Target Among 10 Companies To Announce Annual Dividend Increases In June

Se

Positive

2023-05-29 Buy 8 May Buffett Dividend Dogs And Watch 7

Se

Positive

Glaxosmithkline plc - ADR Overview 30 Nov 2020

Open 35.06

High 35.12

Low 34.80

1 Day Change (Last) 0.35

1 Day Change Percent (Last) 1.01%

Close 34.85

Previous Close 34.50

Volume 1.51M

52 Week High 42.00

52 Week low 27.65

Gross Margin % 67.42%

Net Profit Margin % 16.78%

Total Shares Outstanding 2.05B

Market Capitalization 73.45B

Glaxosmithkline plc - ADR Weight (GSK) 0.04%

Dividends

Dividends Paid (Last Quarter) 555,000,000

Dividends Paid (Last Fiscal Year)3,467,000,000

Dividends Per Share (Last Quarter) 0.27

Dividends Yield (Last Fiscal Year) No Dividends

Dividends Per Share (Last Fiscal Year) No Dividends

Income Statement

Net Income (Last Fiscal Year) 4.92B

1 year Revenue29.32B

Last Quarter Revenue7.16B

4 months EPS revision 3.05